Dementia is a term that describes a group of symptoms that affect memory, thinking, and social abilities severely enough to impact daily life.
13th Annual FDA/ACT-AD Allies Meeting – Common Threads: Learning from the Related Dementias
10:30 AM – 2:30 PM ET
The Accelerate Cures/Treatments for All Dementias (ACT-AD) Coalition’s 13th virtual annual meeting will explore the current therapeutic and research landscape for Alzheimer’s disease and related dementias. The meeting will include presentations on cross-cutting issues between different forms of dementia. The meeting will also feature a forum for receiving updates on the National Institutes of Health’s investment in Alzheimer’s disease and related dementias, the therapeutic pipeline of dementia therapies, recent research on the molecular underpinnings of dementia, academia’s vascular dementia biomarker project, and industry perspectives. A series of expert presentations will be followed by robust discussions with leaders from the National Institute on Aging and the FDA’s Office of Neuroscience, world-leading dementia researchers and academics, and patient advocates.
Please note that this event is not open to the public and is by invitation only. If you have questions or wish to learn about ACT-AD sponsorship opportunities, contact Ryne Carney at [email protected].
The Alliance for Aging Research is a proud recipient of Candid’s Platinum Seal of Transparency.
The Alliance for Aging Research is proud to be rated a 4-star charity by Charity Navigator.